Global Fund 2022 Performance
Abstract:
The Global Fund achieved positive results on lives saved and financial and operational performance in 2022. However, disease incidence reduction progressed to slowly. While there were generally positive trends on key performance, indicators for resilient and sustainable systems for health, final targets were not met for some of them. The OIG 2022 Annual Report warns that the confluence of many major global risks threatens the ability of the Global Fund to deliver on its mission against the three diseases. Attention must therefore be paid to the findings set out in that report. OIG has also drawn attention to the fact that inadequate risk assessment and prioritization of country level interventions have slowed progress in mitigating sexual exploitation, abuse and harassment. Also disappointingly, the Agreed Management Actions Progress Report shows a trend of increasing delays in AMA completion which poses risks for improved grant performance. Steps are needed to identify the reasons for those delays in order to take effective remedial action.
GLOBAL FUND GRANTS IN ANGOLA ARE “PERFORMING POORLY,” OIG SAYS
ABSTRACT
In a routine country audit of Global Fund grants in Angola, the Office of the Inspector General found that the country’s grants were performing poorly. Overall, domestic financing, community engagement, program implementation, as well as data management arrangements, are ineffective, the report said. However, the OIG assessed financial management and assurance arrangements to be partially effective.
OIG AUDIT OF GLOBAL FUND GRANTS TO SOUTH SUDAN HIGHLIGHTS THAT RISK MITIGATION "NEEDS SIGNIFICANT IMPROVEMENT"
ABSTRACT
The Office of the Inspector General, in its second audit of Global Fund grants to South Sudan, found that grant implementation arrangements and financial management and assurance mechanisms were partially effective, while acknowledging the challenges imposed on the country by decades of political instability. The OIG also found that the identification and mitigation of risks related to service delivery, monitoring and evaluation, and procurement and supply chain need significant improvement.
POOR DATA QUALITY FOUND IN GLOBAL FUND GRANTS IN TOGO BUT SUPPLY CHAIN AND IMPLEMENTATION ARRANGEMENTS “PARTIALLY EFFECTIVE,” SAYS OIG
ABSTRACT
The Office of the Inspector General’s opinion resulting from its recent audit of Togo’s Global Fund grants was that the country's systems, processes, and controls on data quality require ‘significant improvement’. However, the OIG found that processes and controls to account for medicines paid for by the Global Fund across the in-country supply chain, as well as grant implementation arrangements, were ‘partially effective’.
Global Fund Secretariat and OIG report steady progress in the implementation of AMAs, but improvement still needed
ABSTRACT
According to a joint progress report by the Secretariat and the OIG, the number of open and overdue Agreed Management Actions (AMAs) was at an all-time low since 2014 when the OIG started tracking closed AMAs systematically. However, some AMAs have remained overdue for years because of changing political environment in the affected countries, developments at the Global Fund, and unforeseen complexities in the implementation of the AMAs.
OIG audits of Global Fund grants to Rwanda and Benin raise issues related to data availability and quality
ABSTRACT
Issues related to the availability and quality of data figured prominently in two audits recently conducted by the Office of the Inspector General on grants to Rwanda and Benin. Because Rwanda’s grants follow a results-based model, the availability of good and reliable data is especially critical.
Follow-up audit of Global Fund grants to Nigeria shows significant improvements, OIG says
ABSTRACT
Since the last audit in 2015, there have been significant improvements, the Office of the Inspector General says in a follow-up audit recently concluded. But there are still many problems that need to be resolved, and some of the mitigation measures already implemented need more time to become effective. The follow-up audit covered the period from July 2016 to September 2017.
Poor stock management contributed to theft of medicines purchased with Global Fund grants to C.A.R., OIG says
ABSTRACT
An investigation conducted by the Office of the Inspector General found that medicines worth almost $200,000 bought using funds from two Global Fund grants were lost due to theft and leakage at a central warehouse managed by a principal recipient in the Central African Republic. The medicines consisted mostly of artemisinin-based combination therapies, but there were also some antiretrovirals. In addition to a large theft in the fourth quarter of 2016, small quantities of medicines regularly went missing over the 17-month period covered by the investigation. The PR, the International Federation of Red Cross and Red Crescent Societies, took issue with some of the OIG’s findings.
Capacity issues and delays in implementation plague otherwise successful Global Fund grants to Zambia, OIG says
ABSTRACT
Despite facing substantial economic challenges, Zambia has successfully scaled up interventions across all three diseases, concluded an audit of Global Fund conducted by the Office of the Inspector General. However, issues concerning the capacity of health workers and the capacity of diagnostic systems have negatively impacted service delivery, the OIG found, and there have been delays in implementing program activities. Finally, Zambia’s health systems operating with obsolete infrastructures struggle to cope with the rapid increase of volumes caused by program scale-up.
Extensions to the Global Fund’s existing HIV and TB grants to Nigeria will be funded from the 2017–2019 allocations
ABSTRACT
Nigeria submitted a TB/HIV funding request in May 2017 which was returned for iteration. Because the revised request has taken (and will take) considerable time to develop, and because the existing TB and HIV grants were scheduled to end on 31 December 2017, the Board has approved 18-month costed extensions for four existing grants. The extensions are to be funded from Nigeria’s 2017-2019 allocation. Meanwhile, the Grant Approvals Committee has reported “widespread frustration” with the slow progress towards impact of Nigeria’s TB grants.